MX9805158A - Adn que codifica una proteina activadora de plasminogeno. - Google Patents

Adn que codifica una proteina activadora de plasminogeno.

Info

Publication number
MX9805158A
MX9805158A MX9805158A MX9805158A MX9805158A MX 9805158 A MX9805158 A MX 9805158A MX 9805158 A MX9805158 A MX 9805158A MX 9805158 A MX9805158 A MX 9805158A MX 9805158 A MX9805158 A MX 9805158A
Authority
MX
Mexico
Prior art keywords
dna encoding
plasminogen activating
activating protein
present
vaccines
Prior art date
Application number
MX9805158A
Other languages
English (en)
Inventor
Everett Lee Rosey
Robert John Yancey Jr
James Andrew Leigh
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9805158A publication Critical patent/MX9805158A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153Streptokinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invencion proporciona moléculas de polinucleotidos que comprenden secuencias de nucleotidos que codifican proteínas activadoras de plasminogeno (PauA) de Streptococcus uberis, y polipéptidos sustancialmente homologos, fragmentos peptídicos y proteínas de fusion de las mismas; la presente invencion además proporciona composiciones y procedimientos para expresar de forma recombinante las proteínas PauA, los polipéptidos sustancialmente homologos, los fragmentos peptídicos y las proteínas de fusion codificadas por las moléculas de polinucleotidos de la presente invencion; la presente invencion proporciona además una vacuna para proteger a un miembro de una especie de mamífero contra la mastitis, que comprende una proteína PauA, un polipéptido sustancialmente homologo, un fragmento peptídico, una proteína de fusion, o una molécula de polinucleotido de la presente invencion.
MX9805158A 1997-06-23 1998-06-23 Adn que codifica una proteina activadora de plasminogeno. MX9805158A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5056597P 1997-06-23 1997-06-23

Publications (1)

Publication Number Publication Date
MX9805158A true MX9805158A (es) 1998-12-31

Family

ID=21965988

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9805158A MX9805158A (es) 1997-06-23 1998-06-23 Adn que codifica una proteina activadora de plasminogeno.

Country Status (13)

Country Link
US (1) US6485904B1 (es)
EP (1) EP0887410A3 (es)
JP (2) JP3577219B2 (es)
CN (2) CN1552856A (es)
AR (1) AR015393A1 (es)
AU (1) AU741724B2 (es)
BR (1) BR9802198A (es)
CA (1) CA2235471C (es)
HK (1) HK1018479A1 (es)
MX (1) MX9805158A (es)
NZ (1) NZ330767A (es)
TW (1) TWI225518B (es)
ZA (1) ZA985414B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
WO2001096379A2 (en) 2000-06-12 2001-12-20 University Of Saskatchewan Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
CN106520951A (zh) * 2016-11-16 2017-03-22 广东海大畜牧兽医研究院有限公司 一种乳房链球菌pauA基因的特异性PCR检测方法
KR20230154048A (ko) * 2021-03-04 2023-11-07 헬릭스 나노테크놀로지스, 인코포레이티드 Sbi 어쥬번트를 포함하는 조성물 및 이들의 이용 방법
CN114736948B (zh) * 2022-06-10 2022-11-08 深圳市帝迈生物技术有限公司 一种α2-抗纤溶酶活性测定试剂盒
CN115116559B (zh) * 2022-06-21 2023-04-18 北京百度网讯科技有限公司 氨基酸中原子坐标的确定及训练方法、装置、设备和介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198214A (en) 1983-08-31 1993-03-30 Stolle Research & Development Corporation Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
GB8904762D0 (en) * 1989-03-02 1989-04-12 Glaxo Group Ltd Biological process
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5234684A (en) 1989-10-24 1993-08-10 Ciba-Geigy Corporation Method for the prevention and treatment of bovine mastitis
GB9201013D0 (en) * 1992-01-17 1992-03-11 Animal Health Inst Vaccines

Also Published As

Publication number Publication date
EP0887410A2 (en) 1998-12-30
EP0887410A3 (en) 2000-12-13
CN1209455A (zh) 1999-03-03
AR015393A1 (es) 2001-05-02
CN1552856A (zh) 2004-12-08
CA2235471A1 (en) 1998-12-23
CN1155708C (zh) 2004-06-30
AU741724B2 (en) 2001-12-06
NZ330767A (en) 2000-02-28
ZA985414B (en) 1999-12-22
JP3577219B2 (ja) 2004-10-13
US6485904B1 (en) 2002-11-26
HK1018479A1 (en) 1999-12-24
BR9802198A (pt) 1999-05-25
CA2235471C (en) 2004-03-30
JPH11103869A (ja) 1999-04-20
TWI225518B (en) 2004-12-21
JP2004073180A (ja) 2004-03-11
AU7310098A (en) 1998-12-24

Similar Documents

Publication Publication Date Title
WO2001083782A3 (en) Novel proteases
EA200100565A1 (ru) Новые стрептококковые антигены
NZ591415A (en) Haemophilus influenzae type B
HUP0302965A2 (hu) Vakcina
BR9713463A (pt) Fitase de bacillus subtilis, gene codificando a referida fitase, método para a produção e uso da mesma
WO2002000860A3 (en) Novel proteases
TR200700740T2 (tr) Nogo genlerinin nükleotid ve protein dizileri ve bunlar bazında yöntemler
EP0837131A3 (en) Staphylococcus fibronectin binding protein compounds
MXPA03001984A (es) Variantes de factor vii de coagulacion humano.
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
RU94046017A (ru) Нуклеиновые кислоты, вектор, клетка или трансгенный организм, синтетические полипептиды, способ получения синтетического пептида, вакцинная композиция, применение нуклеиновой кислоты, способ стимуляции иммунной реакции, олигосахарид
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
MX9805158A (es) Adn que codifica una proteina activadora de plasminogeno.
EP1613345A4 (en) COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320
DE69834194D1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
EP0834568A3 (en) Novel saliva binding protein
PT1141305E (pt) Gene quimerico formado pelas sequencias de adn que codifica os determinantes antigenicos de quatro proteinas de l. infantum
DE69734644D1 (de) Carboxypeptidasen aus aspergillus oryzae und diese kodierende nukleinsäuren
ATE278011T1 (de) Human dnase ii
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
ATE380823T1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
DE69033553D1 (de) Rekombinante herstellung von laktoperoxidase